IFNGR1 and urinary bladder cancer: This finding is in agreement with that made with regard to combination therapy with checkpoint inhibitors for bladder cancer [35], which demonstrated the interdependence of IL-7/IL-7R and IFN-γ/IFN-γR pathways, as well as their necessity for the immune checkpoint blockade to be effective.